TheraVida Initiates Phase 2 Trial of THVD-201 for Overactive Bladder and Urinary Incontinence: selects Novotech
July 5, 2011 by Editor
Filed under Blog, Media Reports 2011
Multi-national Study to be Conducted by Novotech in Australia, New Zealand, and South Korea MOUNTAIN VIEW, California, and SYDNEY, Australia, May 16, 2011 /PRNewswire-iReach/ — TheraVida, Inc., a clinical stage biopharmaceutical company developing novel combination drug products, announced the start of a Phase 2 clinical trial of its lead product candidate THVD-201 for the treatment [...]
New Novotech Media Room!
Check out our new Media Room from Onlinemediarooms.com
